Morphologic, immunologic and genetic features of lymphoproliferative disorders associated with immunodeficiency

  • D. M. Knowles

Abstract

It has been known for a long time that the incidence of malignant lymphoma is greatly increased in individuals who are immunosuppressed, whether this is because of congenital, iatrogenic or acquired immunodeficiency. This chapter is concerned with two categories — those lymphomas which occur following transplantation, and those that are associated with HIV infection [21.1].

Keywords

Europe Lymphoma Sarcoma Cyclosporine Myeloma 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Starzl TE, Nalesnik MA, Porter KA et al. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet 1984; 1: 583–7.PubMedCentralPubMedCrossRefGoogle Scholar
  2. 2.
    Frizzera G, Hanto DW, Gajl-Peczalska KJ et al. Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients. Cancer Res 1981; 41: 4262–79.PubMedGoogle Scholar
  3. 3.
    Nalesnik MA, Jaffe R, Starzl TE et al. The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol 1988; 133:173–92.PubMedGoogle Scholar
  4. 4.
    Knowles DM, Cesarman E, Chadburn A et al. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood 1995; 85: 552–65.PubMedGoogle Scholar
  5. 5.
    Frank D, Cesarman E, Liu YF, Michler RE, Knowles DM. Posttransplantation lymphoproliferative disorders frequently contain type A and not type B Epstein-Barr virus. Blood 1995; 85:1396–403.PubMedGoogle Scholar
  6. 6.
    Knowles DM, Chamulak GA, Subar M et al. Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS). The New York University Medical Center experience with 105 patients (1981–1986). Ann Intern Med 1988; 108: 744–53.PubMedCrossRefGoogle Scholar
  7. 7.
    Pelicci PG, Knowles DM 2nd, Arlin ZAet al. Multiple monoclonal B cell expansions and c-myc oncogene rearrangements in acquired immune deficiency syndrome-related lymphoproliferative disorders. Implications for lymphomagenesis. J Exp Med 1986; 164: 2049–60.PubMedCrossRefGoogle Scholar
  8. 8.
    McGrath MS, Shiramizu B, Meeker TC, Kaplan LD, Herndier B. AIDS-associated polyclonal lymphoma: identification of a new HIV-associated disease process. J Acquir Immune Defic Syndr 1991; 4:408–15.PubMedGoogle Scholar
  9. 9.
    Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 1995; 332: 1186–91.PubMedCrossRefGoogle Scholar
  10. 10.
    Nador RG, Cesarman E, Chadburn A et al. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi’s sarcoma-associated herpes virus. Blood 1996; 88: 645–56.PubMedGoogle Scholar
  11. 11.
    Raphael M, Gentilhomme O, Tulliez M, Byron PA, Diebold J. Histopathologic features of high-grade non-Hodgkin’s lymphomas in acquired immunodeficiency syndrome. The French Study Group of Pathology for Human Immunodeficiency Virus-Associated Tumors. Arch Pathol Lab Med 1991; 115: 15–20.PubMedGoogle Scholar
  12. 12.
    Ballerini P, Gaidano G, Gong JZ et al. Multiple genetic lesions in acquired immunodeficiency syndrome-related non-Hodgkin’s lymphoma. Blood 1993; 81: 166–76.PubMedGoogle Scholar
  13. 13.
    Gaidano G, Lo Coco F, Ye BH et al. Rearrangements of the BCL-6 gene in acquired immunodeficiency syndrome-associated non-Hodgkin’s lymphoma: association with diffuse large-cell subtype. Blood 1994; 84: 397–402.PubMedGoogle Scholar

Copyright information

© Springer-Verlag London 1999

Authors and Affiliations

  • D. M. Knowles

There are no affiliations available

Personalised recommendations